Corpus Intelligence IC Memo — TRINITY ROCK ISLAND 2026-04-26 09:37 UTC
IC Memo — TRINITY ROCK ISLAND
Investment Committee Memorandum | IL | 249 beds | Grade C | EBITDA uplift $24.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TRINITY ROCK ISLAND

CCN 140280 | ROCK ISLAND, IL | 249 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TRINITY ROCK ISLAND is a 249-bed suburban community hospital in ROCK ISLAND, IL with $335.8M in net patient revenue and a -6.9% operating margin. The hospital serves a payer mix of 26.7% Medicare, 0.9% Medicaid, and 72.4% commercial.

Thesis: Undervalued. Our ML models identify $24.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.9% to 0.4% (+736bps).

Net Revenue HCRIS$335.8M
Current EBITDA COMPUTED$-23.3M
Operating Margin COMPUTED-6.9%
Occupancy HCRIS50.4%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS32.0%
Distress Probability ML47.7%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
82
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -6.9% places it below the state median. Among 82 size-comparable peers (124-498 beds), the median margin is -8.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (124-498), prioritizing same-state peers. 82 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TRINITY ROCK ISLAND (Target)IL249$335.8M-6.9%
CENTRAL DUPAGE HOSPITALIL347$1.30B16.4%
CARLE FOUNDATION HOSPITALIL433$1.22B11.8%
ANN & ROBERT H. LURIE CHILDRENIL364$1.17B-12.8%
BOARD OF TRUSTEES OF THE UNIVEIL395$1.14B-12.3%
JOHN H. STROGER JR. HOSP OF COIL429$945.3M-22.4%
SWEDISHAMERICAN HOSPITALIL324$752.0M-2.8%
SPRINGFIELD MEMORIAL HOSPITALIL389$732.9M-14.5%
ADVOCATE NORTHSIDE HEALTH SYSTIL233$713.2M18.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $24.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.1M+210bp18mo
Cost to Collect4.5%2.5%$6.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.1M+122bp9mo
Clean Claim Rate88.0%96.0%$215K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.1M
Cost to Collect
$6.7M
Denial Rate Reduction
$6.6M
A/R Days Reduction
$4.1M
Clean Claim Rate
$215K
Total EBITDA Uplift$24.7M
Current EBITDA$-23.3M
+ RCM Uplift+$24.7M
Pro Forma EBITDA$1.4M
Current Margin-6.9%
Pro Forma Margin0.4%
WC Released (1x)$12.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-35.8M$93.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-35.8M$91.3M0.00x-100.0%
Bull Case9.0x11.0x$-32.2M$161.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-32.2M$166.4M0.00x-100.0%
Bear Case11.0x10.0x$-39.4M$-18.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-39.4M$-33.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 82 hospitals with 124-498 beds
  • Same-state prioritization (n=83)
  • Comp margins: P25=-19.8% / P50=-8.3% / P75=2.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.